Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q1 2025
Institutional positions in Calidi Biotherapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +3 vs. Q4 2024
- Shares held
- 5.46M
- +4.36M (+395.2%) vs. Q4 2024
- Total value
- $3.09M
- +$1.82M (+144.1%) vs. Q4 2024
- New holders
- 8
- 9 more added
- Sold out
- 5
- 6 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $655.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.53M |
| Q4 2023 | 25 | $2.83M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $39.0M |
| Q1 2023 | 27 | $40.6M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $205.5M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $164.7M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3,322,000 | $1.88M | 0.05% | +3,322,000 | New |
| Bank of Montreal | 489,800 | $277.3K | 0.00% | +477,300+3,818.4% | Added |
| Vanguard Group Inc | 353,380 | $200.0K | 0.00% | +292,006+475.8% | Added |
| Geode Capital Management, LLC | 251,916 | $142.6K | 0.00% | +91,898+57.4% | Added |
| Belpointe Asset Management LLC | 249,833 | $141.5K | 0.01% | +249,833 | New |
| HighTower Advisors, LLC | 119,471 | $67.6K | 0.00% | +17,195+16.8% | Added |
| CPR Investments Inc. | 101,000 | $57.2K | 0.05% | 00.0% | Unchanged |
| Red Wave Investments LLC | 80,828 | $45.8K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 61,290 | $34.7K | 0.00% | +38,500+168.9% | Added |
| RS Crum Inc. | 55,313 | $31.3K | 0.01% | +14,850+36.7% | Added |
| Drive Wealth Management, LLC | 55,000 | $31.1K | 0.01% | −35,000−38.9% | Reduced |
| Virtu Financial LLC | 54,737 | $31.0K | 0.00% | −18,711−25.5% | Reduced |
| Northern Trust Corp | 48,693 | $27.6K | 0.00% | +28,760+144.3% | Added |
| Susquehanna International Group, LLP | 32,642 | $18.5K | 0.00% | +9,632+41.9% | Added |
| Delta Investment Management, LLC | 21,023 | $11.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,259 | $11.5K | 0.00% | +20,259 | New |
| Advisor Group Holdings, Inc. | 19,253 | $10.9K | 0.00% | +18,500+2,456.8% | Added |
| XTX Topco Ltd | 16,034 | $9.08K | 0.00% | +16,034 | New |
| Commonwealth Equity Services, LLC | 13,500 | $8.00K | 0.00% | +13,500 | New |
| Highbridge Capital Management LLC | 12,501 | $7.08K | 0.00% | 00.0% | Unchanged |
| Apollo Management Holdings, L.P. | 12,500 | $7.08K | 0.00% | 00.0% | Unchanged |
| Finepoint Capital LP | 12,499 | $7.08K | 0.00% | −10.0% | Reduced |
| GWM Advisors LLC | 11,000 | $6.23K | 0.00% | +11,000 | New |
| Grassi Investment Management | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Avidian Wealth Solutions, LLC | 10,000 | $5.66K | 0.00% | 00.0% | Unchanged |
| Evermay Wealth Management LLC | 6,342 | $3.59K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,116 | $2.90K | 0.00% | +5,116 | New |
| Barrett & Company, Inc. | 3,500 | $1.98K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,019 | $1.14K | 0.00% | −501−19.9% | Reduced |
| Tradewinds Capital Management, LLC | 1,000 | $567 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 500 | $283 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 300 | $170 | 0.00% | +300 | New |
| BlackRock, Inc. | 259 | $147 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 222 | $126 | 0.00% | −835−79.0% | Reduced |
| UBS Group AG | 1 | $1 | 0.00% | −8,798−100.0% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −136,137−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −33,437−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −17,509−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −15,751−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |